Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does statin pretreatment reduce the risk of contrast-induced nephropathy?

Nature Clinical Practice Nephrology volume 2, pages 124–125 (2006)Cite this article

boxed-textKhanal S et al. (2005) Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med 118: 843–849

Patients at high risk of contrast nephropathy should receive prior volume expansion with sodium chloride, N-acetylcysteine and bicarbonate; statin pretreatment is promising but not currently recommended

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Persson PB et al. (2005) Pathophysiology of contrast medium-induced nephropathy. Kidney Int 68: 14–22

    Article  CAS  Google Scholar 

  2. Merten GJ et al. (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291: 2328–2334

    Article  CAS  Google Scholar 

  3. Yokota N et al. (2003) Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol 23: 13–17

    Article  CAS  Google Scholar 

  4. Attallah N et al. (2004) The potential role of statins in contrast nephropathy. Clin Nephrol 62: 273–278

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Physician Director of Kidney and Pancreas Transplantation at Johns Hopkins University, Baltimore, MD, USA

    Hamid Rabb

Authors
  1. Hamid Rabb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hamid Rabb.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rabb, H. Does statin pretreatment reduce the risk of contrast-induced nephropathy?. Nat Rev Nephrol 2, 124–125 (2006). https://doi.org/10.1038/ncpneph0126

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0126

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing